"Illustration of Dupixent Treatment"
Drug Updates

Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy. Japan is the […]

Hospital Updates

Toyota Tsusho and Tokai Corp join hands to launch Valabhi Hospital Services in India

Toyota Tsusho Corporation, a global trading company within the Toyota Group, and Tokai Corp, a specialist in hospital linen supply and medical peripheral businesses in Japan, have announced the launch of Valabhi Hospital Services in India. The joint venture aims to revolutionize hospital linen management and offer improved hygiene in healthcare institutions. Valabhi Hospital Services […]

Japan-based Instalimb introduced advanced quality prosthetic legs with personalized solutions in the Indian Market
BusinessWire

World’s First 3D Designed Prosthetic Leg Provider from Japan Forays into Indian Market with a Funding of Rs. 26 Crore

Japan based world’s first 3D-printed prosthetic legs maker Instalimb raised 445 million yen (Rs. 26 crore) in Series A funding in Japan (including investment, loans, and grants) to foray into the Indian market and launched its technologically advanced prosthetic wear solutions in Gurgaon on 1st of July.Instalimb promises value proposition to the Indian market by […]

Digital Health News

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted

Tokyo:  CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe.  The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In fact, […]